Latest filings (excl ownership)
15-12B
Securities registration termination
1 Nov 19
POSASR
Automatic shelf registration (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Oct 19
25-NSE
Exchange delisting
22 Oct 19
SC 14D9/A
Tender offer solicitation (amended)
22 Oct 19
SC TO-T/A
Third party tender offer statement (amended)
22 Oct 19
8-K
Entry into a Material Definitive Agreement
22 Oct 19
SC TO-T/A
Third party tender offer statement (amended)
17 Oct 19
SC 14D9/A
Tender offer solicitation (amended)
16 Oct 19
SC 14D9/A
Tender offer solicitation (amended)
11 Oct 19
SC 14D9/A
Tender offer solicitation (amended)
11 Oct 19
SC TO-T/A
Third party tender offer statement (amended)
10 Oct 19
SC TO-T/A
Third party tender offer statement (amended)
4 Oct 19
SC 14D9/A
Tender offer solicitation (amended)
4 Oct 19
UPLOAD
Letter from SEC
3 Oct 19
SC TO-T/A
Third party tender offer statement (amended)
1 Oct 19
SC 14D9/A
Tender offer solicitation (amended)
1 Oct 19
SC TO-T/A
Third party tender offer statement (amended)
27 Sep 19
SC 14D9/A
Tender offer solicitation (amended)
26 Sep 19
SC 14D9
Tender offer solicitation
23 Sep 19
SC TO-T
Third party tender offer statement
23 Sep 19
SC TO-C
Information about tender offer
18 Sep 19
SC14D9C
Written communication relating to third party tender offer
16 Sep 19
SC TO-C
Information about tender offer
16 Sep 19
8-K
Tender and Support Agreement
16 Sep 19
8-K
Alder BioPharmaceuticals® Reports Second Quarter 2019 Financial and Operating Results
6 Aug 19
10-Q
2019 Q2
Quarterly report
6 Aug 19
8-K
Submission of Matters to a Vote of Security Holders
24 May 19
8-K
Other Events
2 May 19
424B7
Prospectus with selling stockholder info
2 May 19
8-K
Alder BioPharmaceuticals® Reports First Quarter 2019 Financial and Operating Results
2 May 19
10-Q
2019 Q1
Quarterly report
2 May 19
DEF 14A
Definitive proxy
30 Apr 19
CT ORDER
Confidential treatment order
15 Apr 19
Latest ownership filings
SC 13G/A
Beneficial ownership report (amended)
13 Feb 20
SC 13G
Beneficial ownership report
31 Oct 19
SC 13D/A
Alder Biopharmaceuticals Inc
25 Oct 19
4
Carlos Campoy
24 Oct 19
4
PAUL STRECK
24 Oct 19
4
Nadia Dac
24 Oct 19
4
Jeremy Green
24 Oct 19
4
Erin Lavelle
24 Oct 19
4
James B Bucher
24 Oct 19
4
Randal Hassler
24 Oct 19
4
Jeffrey T L Smith
24 Oct 19
4
WENDY L YARNO
24 Oct 19
4
CLAY B SIEGALL
24 Oct 19
4
Heather Preston
24 Oct 19
4
Alan Bruce Montgomery
24 Oct 19
4
Paul B Cleveland
24 Oct 19
4
Paul Rutherford Carter
24 Oct 19
4
Robert Azelby
24 Oct 19
4
LUNDBECK A S H
24 Oct 19
SC 13D/A
Alder Biopharmaceuticals Inc
24 Oct 19
SC 13G/A
Alder Biopharmaceuticals Inc
10 Oct 19
SC 13G/A
Alder Biopharmaceuticals Inc
10 Oct 19
3
LUNDBECK A S H
26 Sep 19
SC 13D
Alder Biopharmaceuticals Inc
26 Sep 19
4
Jeffrey T L Smith
18 Sep 19
SC 13D/A
Alder Biopharmaceuticals Inc
17 Sep 19
4
Jeremy Green
1 Jul 19
4
WENDY L YARNO
28 May 19
4
CLAY B SIEGALL
28 May 19
4
Alan Bruce Montgomery
28 May 19
4
Paul Rutherford Carter
28 May 19
4
Paul B Cleveland
28 May 19
4
Jeremy Green
24 May 19
4
Robert Azelby
25 Apr 19
4
Randal Hassler
25 Apr 19
4
Larry Benedict
25 Apr 19
4
Jeffrey T L Smith
25 Apr 19
4
Erin Lavelle
25 Apr 19
4
James B Bucher
25 Apr 19
4
Nadia Dac
10 Apr 19